Article ID Journal Published Year Pages File Type
5528996 Nuclear Medicine and Biology 2017 4 Pages PDF
Abstract

IntroductionTechnetium-99m-hexamethylpropyleneamine oxime (99mTc-HMPAO) is potentially useful for the assessment of cerebral blood flow (CBF) in small animals. In this paper, a procedure for quantitation of rat CBF using 99mTc-HMPAO was determined.MethodsBiodistribution of 99mTc-radioactivity in normal rats was determined after intravenous administration of 99mTc-HMPAO. Acetazolamide treated rats were intravenously administered with the mixture of 99mTc-HMPAO and N-isopropyl-[125I]iodoamphetamine ([125I]IMP), and arterial blood was then collected for 5 min. After blood sampling, the brain radioactivity concentration was measured with the auto-well γ counter.ResultsThe brain radioactivity concentration after intravenous administration of 99mTc-HMPAO was steady from 14 s to 60 min post-injection. A double tracer experiment using 99mTc-HMPAO and [125I]IMP showed that 19 s was the average of the optimal integration interval of arterial blood 99mTc-radioactivity concentration to obtain CBF values measured by 99mTc-HMPAO identical to those determined by [125I]IMP. The CBF value determined by 99mTc-HMPAO, calculated by dividing the brain radioactivity concentration at 5 min post-injection by the integrated arterial blood radioactivity concentration until 19 s post-injection, was well correlated with CBF as determined by [125I]IMP.ConclusionThese results suggest that the CBF quantitation procedure described in this paper could be useful for rat CBF assessment.

Related Topics
Life Sciences Biochemistry, Genetics and Molecular Biology Cancer Research
Authors
, , , ,